Advance Agrolife Limited – Investor Presentation Summary
Key Operational Highlights
- Installed capacity of nearly 90,000 MTPA across three integrated manufacturing facilities
- Presence in 19 States & 2 Union Territories with exports to 7 countries (UAE, Bangladesh, China, Turkey, Egypt, Kenya, Nepal)
- 410+ CIB & RC registrations (380 Formulations & 30 Technicals) creating regulatory entry barriers
- Top 10 customers contribute ~69% of revenue including DCM Shriram, NFL, Zuari Ind, IFFCO, Coromandel, Mankind Agritech, HPM, Indogulf
- Pure-play B2B manufacturing strategy with zero marketing spend and minimized credit risk
Key drivers of operational performance: Backward integration into technical production, strategic location in Jaipur creating freight arbitrage, and specialized Sulphur formulation capabilities
Segment-wise Performance
Not Specified
Financial Highlights
Revenue: ₹3304 million (Q1 FY27)
EBITDA: ₹351 million (Q1 FY27)
PAT: ₹225.4 million (Q1 FY27)
EPS: ₹35 (Q1 FY27)
Margins: EBITDA margin at 10.6% (Q1 FY27)
YoY/QoQ comparison: Revenue increased 96% Y-o-Y and 167% Q-o-Q; PAT increased 152% Y-o-Y and 202% Q-o-Q
Drivers of financial performance: Higher revenue growth, operational efficiencies from backward integration, and adequate inventory management
Comparison to market estimates: Not Specified
Key Risks: Not Specified
Geographical Revenue Split
Domestic vs Export/Regional Revenue: Exports contribute ~2% of revenue
Domestic: Not Specified
Export: Not Specified
Regional Breakdown: Presence in UAE, Turkey, Egypt, Kenya, Nepal, Bangladesh, China
Balance Sheet Snapshot
Net Debt/Equity: Not Specified
Reserves: ₹2456.3 million (FY26)
Current Assets/Liabilities: Not Specified
Working Capital/Leverage Metrics: Not Specified
Financial Health Insights: Working capital strengthened through IPO proceeds enabling uninterrupted supplies
Capex & Cash Flow Health
Capital Expenditure: Construction of Unit-5 manufacturing facility at Dahej II GIDC Industrial Estate on 17,734.54 sq. mtrs land
Free Cash Flow: Not Specified
Operating Cash Flow: Not Specified
Net Debt Movement: Not Specified
Investment Rationale: Enhance production capacity and support long-term growth strategy for technical grade pesticides
Strategic & R&D Initiatives
Investments in Innovation: Conversion of Unit I to technical production, Unit IV expansion for fungicides/herbicides, 2,4-D capacity expansion from 2,500 MT to 10,000 MT
Expected impact on growth: Targets 25-30% reduction in COGS for specific products through backward integration
Strategic Rationale: Shift from net buyer to net manufacturer of technicals to capture full molecular margin
Industry Trends & Business Environment
Macro/Industry Trends: Government anti-dumping duties on Pretilachlor and its intermediate PEDA imported from China
Impact on Company: Creates pricing umbrella for domestic manufacturers; company has 13 TPD capacity for Pretilachlor and commenced captive manufacturing of PEDA
Management Commentary & Growth Outlook
Strategic Outlook: "With a strong operational foundation and a clear growth strategy, we remain confident about the opportunities ahead and look forward to the rest of FY2027 with optimism and enthusiasm" - Omprakash Choudhary, CMD
FY Guidance: Increase export share to 20% of revenue by FY29; target registration in regulated markets (LATAM, SE Asia, Brazil)
Market Share Targets: Not Specified
Risks and Opportunities: Geopolitical uncertainties and supply chain disruptions mentioned as challenges
Additional Headings:
Production Facilities:
- Unit I (Bagru, Jaipur): Technical hub for Herbicides/Fungicides and Technical intermediates
- Unit II (Dahami Khurd, Jaipur): Specialized in Sulphur 80% WDG, Sulphur 80% WP, and Tebuconazole blends
- Unit III (Dahami Khurd, Jaipur): Liquid Insecticides, Herbicides, and Bio-fertilizers
- Unit IV: Technical manufacturing facility at Gidani (Raj.) expected to commence operations by Q3 FY27